Two splice variants of y chromosome-located lysine-specific Demethylase 5D have distinct function in prostate cancer cell line (DU-145)

Journal of Proteome Research

Volumn 14, Issue 9, 2015, Pages 3492-3502

  Jangravi, Zohreh ^a,b   Tabar, Mehdi Sharif ^a   Mirzaei, Mehdi ^c   Parsamatin, Pouria ^a   Vakilian, Haghighat ^a   Alikhani, Mehdi ^a   Shabani, Mohammad ^b   Haynes, Paul A ^d   Goodchild, Ann K ^c   Gourabi, Hamid ^a   Baharvand, Hossein ^a,e   Salekdeh, Ghasem Hosseini ^a,f  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MACQUARIE UNIVERSITY   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

^e UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

^f AGRICULTURAL BIOTECHNOLOGY RESEARCH INSTITUTE OF IRAN ABRII   (Iran)

Author keywords

Human Proteome Project; lysine (K) specific demethylase 5D (KDM5D); short interfering RNA (siRNA); shotgun proteomics

Indexed keywords

LYSINE; LYSINE SPECIFIC DEMETHYLASE 5D; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HISTONE DEMETHYLASE; KDM5D PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CANCER GROWTH; CHROMOSOME VARIANT; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LNCAP CELL LINE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROSTATE CARCINOMA; PROTEOMICS; Y CHROMOSOME; ENZYMOLOGY; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLISM; PROSTATE TUMOR; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE;

ALTERNATIVE SPLICING; APOPTOSIS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMOSOMES, HUMAN, Y; DOWN-REGULATION; HISTONE DEMETHYLASES; HUMANS; MALE; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; TANDEM MASS SPECTROMETRY;

EID: 84941140032     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00333     Document Type: Article

References (59)

1. Legrain, P.; Aebersold, R.; Archakov, A.; Bairoch, A.; Bala, K.; Beretta, L.; Bergeron, J.; Borchers, C. H.; Corthals, G. L.; Costello, C. E., The human proteome project: current state and future direction. Mol. Cell. Proteomics 2011, 10, (7), M111.009993 10.1074/mcp.M111.009993.
2. Paik, Y. K.; Omenn, G. S.; Uhlen, M.; Hanash, S.; Marko-Varga, G.; Aebersold, R.; Bairoch, A.; Yamamoto, T.; Legrain, P.; Lee, H. J.; Na, K.; Jeong, S. K.; He, F.; Binz, P. A.; Nishimura, T.; Keown, P.; Baker, M. S.; Yoo, J. S.; Garin, J.; Archakov, A.; Bergeron, J.; Salekdeh, G. H.; Hancock, W. S. Standard guidelines for the chromosome-centric human proteome project J. Proteome Res. 2012, 11 (4) 2005-13 10.1021/pr200824a
3. Blair, L. P.; Cao, J.; Zou, M. R.; Sayegh, J.; Yan, Q. Epigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer Cancers 2011, 3 (1) 1383-404 10.3390/cancers3011383
4. Klose, R. J.; Kallin, E. M.; Zhang, Y. JmjC-domain-containing proteins and histone demethylation Nat. Rev. Genet. 2006, 7 (9) 715-27 10.1038/nrg1945
5. Shi, Y. Histone lysine demethylases: emerging roles in development, physiology and disease Nat. Rev. Genet. 2007, 8 (11) 829-33 10.1038/nrg2218
6. Liang, G.; Lin, J. C.; Wei, V.; Yoo, C.; Cheng, J. C.; Nguyen, C. T.; Weisenberger, D. J.; Egger, G.; Takai, D.; Gonzales, F. A.; Jones, P. A. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome Proc. Natl. Acad. Sci. U. S. A. 2004, 101 (19) 7357-62 10.1073/pnas.0401866101
7. Lee, M. G.; Norman, J.; Shilatifard, A.; Shiekhattar, R. Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein Cell 2007, 128 (5) 877-87 10.1016/j.cell.2007.02.004
8. Akimoto, C.; Kitagawa, H.; Matsumoto, T.; Kato, S. Spermatogenesis-specific association of SMCY and MSH5 Genes Cells 2008, 13 (6) 623-33 10.1111/j.1365-2443.2008.01193.x
9. Perinchery, G.; Sasaki, M.; Angan, A.; Kumar, V.; Carroll, P.; Dahiya, R. Deletion of Y-chromosome specific genes in human prostate cancer J. Urol. 2000, 163 (4) 1339-42 10.1016/S0022-5347(05)67774-9
10. Fathi, A.; Hatami, M.; Hajihosseini, V.; Fattahi, F.; Kiani, S.; Baharvand, H.; Salekdeh, G. H. Comprehensive gene expression analysis of human embryonic stem cells during differentiation into neural cells PLoS One 2011, 6 (7) e22856 10.1371/journal.pone.0022856
11. Mirzaei, M.; Soltani, N.; Sarhadi, E.; George, I. S.; Neilson, K. A.; Pascovici, D.; Shahbazian, S.; Haynes, P. A.; Atwell, B. J.; Salekdeh, G. H. Manipulating root water supply elicits major shifts in the shoot proteome J. Proteome Res. 2014, 13 (2) 517-26 10.1021/pr400696u
12. Krijgsveld, J.; Gauci, S.; Dormeyer, W.; Heck, A. J. In-gel isoelectric focusing of peptides as a tool for improved protein identification J. Proteome Res. 2006, 5 (7) 1721-30 10.1021/pr0601180
13. Zybailov, B.; Mosley, A. L.; Sardiu, M. E.; Coleman, M. K.; Florens, L.; Washburn, M. P. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae J. Proteome Res. 2006, 5 (9) 2339-47 10.1021/pr060161n
14. Bateman, A.; Coin, L.; Durbin, R.; Finn, R. D.; Hollich, V.; Griffiths-Jones, S.; Khanna, A.; Marshall, M.; Moxon, S.; Sonnhammer, E. L. The Pfam protein families database Nucleic acids research 2004, 32 (suppl 1) D138-D141 10.1093/nar/gkh121
15. Patsialou, A.; Wilsker, D.; Moran, E. DNA-binding properties of ARID family proteins Nucleic Acids Res. 2005, 33 (1) 66-80 10.1093/nar/gki145
16. Kortschak, R. D.; Tucker, P. W.; Saint, R. ARID proteins come in from the desert Trends Biochem. Sci. 2000, 25 (6) 294-299 10.1016/S0968-0004(00)01597-8
17. Pascual, J.; Martinez-Yamout, M.; Dyson, H. J.; Wright, P. E. Structure of the PHD zinc finger from human Williams-Beuren syndrome transcription factor J. Mol. Biol. 2000, 304 (5) 723-729 10.1006/jmbi.2000.4308
18. Trewick, S. C.; McLaughlin, P. J.; Allshire, R. C. Methylation: lost in hydroxylation? EMBO Rep. 2005, 6 (4) 315-320 10.1038/sj.embor.7400379
19. Clissold, P. M.; Ponting, C. P. JmjC: cupin metalloenzyme-like domains in jumonji, hairless and phospholipase A 2 β Trends Biochem. Sci. 2001, 26 (1) 7-9 10.1016/S0968-0004(00)01700-X
20. Lu, P. J.; Sundquist, K.; Baeckstrom, D.; Poulsom, R.; Hanby, A.; Meier-Ewert, S.; Jones, T.; Mitchell, M.; Pitha-Rowe, P.; Freemont, P. A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer J. Biol. Chem. 1999, 274 (22) 15633-15645 10.1074/jbc.274.22.15633
21. Suzuki, T.; Minehata, K.; Akagi, K.; Jenkins, N. A.; Copeland, N. G. Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice EMBO J. 2006, 25 (14) 3422-31 10.1038/sj.emboj.7601215
22. Barrett, A.; Madsen, B.; Copier, J.; Lu, P. J.; Cooper, L.; Scibetta, A. G.; Burchell, J.; Taylor-Papadimitriou, J. PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen? Int. J. Cancer 2002, 101 (6) 581-8 10.1002/ijc.10644
23. Lu, P. J.; Sundquist, K.; Baeckstrom, D.; Poulsom, R.; Hanby, A.; Meier-Ewert, S.; Jones, T.; Mitchell, M.; Pitha-Rowe, P.; Freemont, P.; Taylor-Papadimitriou, J. A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer J. Biol. Chem. 1999, 274 (22) 15633-45 10.1074/jbc.274.22.15633
24. Yamane, K.; Tateishi, K.; Klose, R. J.; Fang, J.; Fabrizio, L. A.; Erdjument-Bromage, H.; Taylor-Papadimitriou, J.; Tempst, P.; Zhang, Y. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation Mol. Cell 2007, 25 (6) 801-12 10.1016/j.molcel.2007.03.001
25. Luo, J. H. Oncogenic activity of MCM7 transforming cluster World J. Clin Oncol 2011, 2 (2) 120-4 10.5306/wjco.v2.i2.120
26. Scian, M. J.; Carchman, E. H.; Mohanraj, L.; Stagliano, K. E.; Anderson, M. A.; Deb, D.; Crane, B. M.; Kiyono, T.; Windle, B.; Deb, S. P.; Deb, S. Wild-type p53 and p73 negatively regulate expression of proliferation related genes Oncogene 2008, 27 (18) 2583-93 10.1038/sj.onc.1210898
27. Tang, Y.; Horikawa, I.; Ajiro, M.; Robles, A. I.; Fujita, K.; Mondal, A. M.; Stauffer, J. K.; Zheng, Z. M.; Harris, C. C. Downregulation of splicing factor SRSF3 induces p53beta, an alternatively spliced isoform of p53 that promotes cellular senescence Oncogene 2013, 32 (22) 2792-8 10.1038/onc.2012.288
28. Kurokawa, K.; Akaike, Y.; Masuda, K.; Kuwano, Y.; Nishida, K.; Yamagishi, N.; Kajita, K.; Tanahashi, T.; Rokutan, K. Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells Oncogene 2014, 33 (11) 1407-17 10.1038/onc.2013.86
29. Rasheed, S. A.; Teo, C. R.; Beillard, E. J.; Voorhoeve, P. M.; Casey, P. J. MicroRNA-182 and microRNA-200a control G-protein subunit alpha-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells J. Biol. Chem. 2013, 288 (11) 7986-95 10.1074/jbc.M112.437749
30. Yoshino, H.; Enokida, H.; Chiyomaru, T.; Tatarano, S.; Hidaka, H.; Yamasaki, T.; Gotannda, T.; Tachiwada, T.; Nohata, N.; Yamane, T.; Seki, N.; Nakagawa, M. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer Biochem. Biophys. Res. Commun. 2012, 417 (1) 588-93 10.1016/j.bbrc.2011.12.011
31. Wagner, E. F.; Nebreda, A. R. Signal integration by JNK and p38 MAPK pathways in cancer development Nat. Rev. Cancer 2009, 9 (8) 537-49 10.1038/nrc2694
32. Barbaric, D.; Byth, K.; Dalla-Pozza, L.; Byrne, J. A. Expression of tumor protein D52-like genes in childhood leukemia at diagnosis: clinical and sample considerations Leuk. Res. 2006, 30 (11) 1355-63 10.1016/j.leukres.2006.03.009
33. Boutros, R.; Byrne, J. A. D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells Exp. Cell Res. 2005, 310 (1) 152-65 10.1016/j.yexcr.2005.07.009
34. Jiang, H.; Lin, J. J.; Tao, J.; Fisher, P. B. Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-beta Oncogene 1997, 14 (4) 473-80 10.1038/sj.onc.1200858
35. Li, C.; Ge, M.; Yin, Y.; Luo, M.; Chen, D. Silencing expression of ribosomal protein L26 and L29 by RNA interfering inhibits proliferation of human pancreatic cancer PANC-1 cells Mol. Cell. Biochem. 2012, 370 (1-2) 127-39 10.1007/s11010-012-1404-x
36. Zeng, Y.; Abdallah, A.; Lu, J. P.; Wang, T.; Chen, Y. H.; Terrian, D. M.; Kim, K.; Lu, Q. delta-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles Mol. Cancer 2009, 8, 19 10.1186/1476-4598-8-19
37. Liu, S.; Wang, X.; Sun, F.; Kong, J.; Li, Z.; Lin, Z. DEK overexpression is correlated with the clinical features of breast cancer Pathol. Int. 2012, 62 (3) 176-81 10.1111/j.1440-1827.2011.02775.x
38. Scott, M. S.; Boisvert, F. M.; McDowall, M. D.; Lamond, A. I.; Barton, G. J. Characterization and prediction of protein nucleolar localization sequences Nucleic Acids Res. 2010, 38 (21) 7388-99 10.1093/nar/gkq653
39. Wang, W.; Chen, Z.; Mao, Z.; Zhang, H.; Ding, X.; Chen, S.; Zhang, X.; Xu, R.; Zhu, B. Nucleolar protein Spindlin1 recognizes H3K4 methylation and stimulates the expression of rRNA genes EMBO Rep. 2011, 12 (11) 1160-6 10.1038/embor.2011.184
40. Frescas, D.; Guardavaccaro, D.; Bassermann, F.; Koyama-Nasu, R.; Pagano, M. JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes Nature 2007, 450 (7167) 309-13 10.1038/nature06255
41. Donati, G.; Montanaro, L.; Derenzini, M. Ribosome biogenesis and control of cell proliferation: p53 is not alone Cancer Res. 2012, 72 (7) 1602-7 10.1158/0008-5472.CAN-11-3992
42. Shenoy, N.; Kessel, R.; Bhagat, T. D.; Bhattacharya, S.; Yu, Y.; McMahon, C.; Verma, A. Alterations in the ribosomal machinery in cancer and hematologic disorders J. Hematol. Oncol. 2012, 5, 32 10.1186/1756-8722-5-32
43. Bhavsar, R. B.; Makley, L. N.; Tsonis, P. A. The other lives of ribosomal proteins Hum. Genomics 2010, 4 (5) 327-44 10.1186/1479-7364-4-5-327
44. Ohkia, A.; Hu, Y.; Wang, M.; Garcia, F. U.; Stearns, M. E. Evidence for prostate cancer-associated diagnostic marker-1: immunohistochemistry and in situ hybridization studies Clin. Cancer Res. 2004, 10 (7) 2452-8 10.1158/1078-0432.CCR-03-0170
45. Bee, A.; Ke, Y.; Forootan, S.; Lin, K.; Beesley, C.; Forrest, S. E.; Foster, C. S. Ribosomal protein l19 is a prognostic marker for human prostate cancer Clin. Cancer Res. 2006, 12 (7 Pt 1) 2061-5 10.1158/1078-0432.CCR-05-2445
46. Vaarala, M. H.; Porvari, K. S.; Kyllonen, A. P.; Mustonen, M. V.; Lukkarinen, O.; Vihko, P. T. Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cell lines: confirmation of L7a and L37 over-expression in prostate-cancer tissue samples Int. J. Cancer 1998, 78 (1) 27-32 10.1002/(SICI)1097-0215(19980925)78:1<27::AID-IJC6>3.3.CO;2-A
47. Guo, X.; Shi, Y.; Gou, Y.; Li, J.; Han, S.; Zhang, Y.; Huo, J.; Ning, X.; Sun, L.; Chen, Y.; Sun, S.; Fan, D. Human ribosomal protein S13 promotes gastric cancer growth through down-regulating p27(Kip1) J. Cell Mol. Med. 2011, 15 (2) 296-306 10.1111/j.1582-4934.2009.00969.x
48. Grosso, A. R.; Martins, S.; Carmo-Fonseca, M. The emerging role of splicing factors in cancer EMBO Rep. 2008, 9 (11) 1087-93 10.1038/embor.2008.189
49. Licatalosi, D. D.; Darnell, R. B. RNA processing and its regulation: global insights into biological networks Nat. Rev. Genet. 2010, 11 (1) 75-87 10.1038/nrg2673
50. Kimball, S. R. Eukaryotic initiation factor eIF2 Int. J. Biochem. Cell Biol. 1999, 31 (1) 25-9 10.1016/S1357-2725(98)00128-9
51. He, Y.; Correa, A. M.; Raso, M. G.; Hofstetter, W. L.; Fang, B.; Behrens, C.; Roth, J. A.; Zhou, Y.; Yu, L.; Wistuba, II; Swisher, S. G.; Pataer, A. The role of PKR/eIF2alpha signaling pathway in prognosis of non-small cell lung cancer PLoS One 2011, 6 (11) e24855 10.1371/journal.pone.0024855
52. Mounir, Z.; Krishnamoorthy, J. L.; Robertson, G. P.; Scheuner, D.; Kaufman, R. J.; Georgescu, M. M.; Koromilas, A. E. Tumor suppression by PTEN requires the activation of the PKR-eIF2alpha phosphorylation pathway Sci. Signaling 2009, 2 (102) ra85 10.1126/scisignal.2000389
53. Dowling, R. J.; Topisirovic, I.; Fonseca, B. D.; Sonenberg, N. Dissecting the role of mTOR: lessons from mTOR inhibitors Biochim. Biophys. Acta, Proteins Proteomics 2010, 1804 (3) 433-9 10.1016/j.bbapap.2009.12.001
54. Hay, N.; Sonenberg, N. Upstream and downstream of mTOR Genes Dev. 2004, 18 (16) 1926-45 10.1101/gad.1212704
55. Brown, E. J.; Albers, M. W.; Shin, T. B.; Ichikawa, K.; Keith, C. T.; Lane, W. S.; Schreiber, S. L. A mammalian protein targeted by G1-arresting rapamycin-receptor complex Nature 1994, 369 (6483) 756-8 10.1038/369756a0
56. Flynn, A.; Proud, C. G. The role of eIF4 in cell proliferation Maturitas 1996, 27, 293-310 10.1016/S0378-5122(97)80855-9
57. Graff, J. R.; Konicek, B. W.; Carter, J. H.; Marcusson, E. G. Targeting the eukaryotic translation initiation factor 4E for cancer therapy Cancer Res. 2008, 68 (3) 631-4 10.1158/0008-5472.CAN-07-5635
58. Zhang, Y. I-TASSER server for protein 3D structure prediction BMC Bioinf. 2008, 9 (1) 40 10.1186/1471-2105-9-40
59. Vizcaino, J. A.; Cote, R. G.; Csordas, A.; Dianes, J. A.; Fabregat, A.; Foster, J. M.; Griss, J.; Alpi, E.; Birim, M.; Contell, J.; O'Kelly, G.; Schoenegger, A.; Ovelleiro, D.; Perez-Riverol, Y.; Reisinger, F.; Rios, D.; Wang, R.; Hermjakob, H. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013 Nucleic Acids Res. 2013, 41 (Database issue) D1063-9 10.1093/nar/gks1262